Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Balaxi Pharmaceuticals Ltd

BALAXI.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.25

▲ +0.04%

Market Cap $13.70M · Vol 25.97K

Key Metrics

P/E Ratio

54.29

FWD: N/A

Market Cap

$13.70M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

43.25

Momentum

Beta

1.78

vs Market

52W High

$0.52

55.80% below

52W Low

$0.16

56.80% above

Volume

25.97K

Avg 25.42K

P/B

0.34

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Balaxi Pharmaceuticals Ltd (BALAXI.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BALAXI.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.32%

-0.54%

-9.19%

+9.89%

YTD

-10.68%

-49.70%

-77.76%

-79.04%

Financials & Valuation

TTM · Annual

Total Revenue	$28.91M
Net Income	$151.61K
Revenue Growth (YoY)	+14.05%
Gross Margin	43.34%
Operating Margin	2.38%
Net Profit Margin	0.52%
ROE	N/A
ROA · ROIC	1.64% · 0.83%

P/E Ratio	54.29
Forward P/E (FY1)	N/A
PEG Ratio	-0.65
P/S	0.32
P/B	0.34
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	54.49M

Technical Indicators

50-Day SMA	$0.25
200-Day SMA	$0.28
RSI (14)	43.25
Beta	1.78
52-Week High	$0.52
52-Week Low	$0.16

Volume Today	25.97K
Avg Daily Volume (30D)	25.42K
Relative Volume	1.02x
Volatility (10D)	15.15
Volatility (30D)	17.44
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.25

Mean Target N/A

52W Low$0.16 52W High$0.52

Current

Target

$0.16 $0.52

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001V0C491

ISININE618N01022

CountryIndia

Sub-IndustryPharmaceuticals Wholesale

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MCK McKesson Corp +1.44% CAH Cardinal Health, Inc +1.70% SIG.AX Sigma Healthcare Ltd +0.00% 000963.SZ Huadong Medicine Co Ltd +0.54% HLUN A.CO H Lundbeck A/S +0.56%

Company Profile

Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.